Thoracic radiation therapy in limited stage small-cell lung cancer: Timing is everything ... isn't it?

被引：8
作者：
Perry, Michael C. [1 ]
机构：
[1] Univ Missouri, Ellis Fischel Canc Ctr, Columbia, MO 65211 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 24期
关键词：
D O I：
10.1200/JCO.2006.07.2827
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3815 / 3816
页数：2
相关论文
共 10 条
[1]   PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG-CANCER IN COMPLETE REMISSION [J].
ARRIAGADA, R ;
LECHEVALIER, T ;
BORIE, F ;
RIVIERE, A ;
CHOMY, P ;
MONNET, I ;
TARDIVON, A ;
VIADER, F ;
TARAYRE, M ;
BENHAMOU, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (03) :183-190
[2]   Scheduling of radiation and chemotherapy for limited-stage small-cell lung cancer: Repopulation as a cause of treatment failure? [J].
Brade, AM ;
Tannock, IF .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1020-1022
[3]   Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer [J].
De Ruysscher, D ;
Pijls-Johannesma, M ;
Bentzen, SM ;
Minken, A ;
Wanders, R ;
Lutgens, L ;
Hochstenbag, M ;
Boersma, L ;
Wouters, B ;
Lammering, G ;
Vansteenkiste, J ;
Lambin, P .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1057-1063
[4]   Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer [J].
Fried, DB ;
Morris, DE ;
Poole, C ;
Rosenman, JG ;
Halle, JS ;
Detterbeck, FC ;
Hensing, TA ;
Socinski, MA .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) :4837-4845
[5]   IMPORTANCE OF TIMING FOR THORACIC IRRADIATION IN THE COMBINED MODALITY TREATMENT OF LIMITED-STAGE SMALL-CELL LUNG-CANCER [J].
MURRAY, N ;
COY, P ;
PATER, JL ;
HODSON, I ;
ARNOLD, A ;
ZEE, BC ;
PAYNE, D ;
KOSTASHUK, EC ;
EVANS, WK ;
DIXON, P ;
SADURA, A ;
FELD, R ;
LEVITT, M ;
WIERZBICKI, R ;
AYOUB, J ;
MAROUN, JA ;
WILSON, KS .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (02) :336-344
[6]   Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: An update of Cancer and Leukemia Group B study 8083 [J].
Perry, MC ;
Herndon, JE ;
Eaton, WL ;
Green, MR .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) :2466-2467
[7]   A METAANALYSIS OF THORACIC RADIOTHERAPY FOR SMALL-CELL LUNG-CANCER [J].
PIGNON, JP ;
ARRIAGADA, R ;
IHDE, DC ;
JOHNSON, DH ;
PERRY, MC ;
SOUHAMI, RL ;
BRODIN, O ;
JOSS, RA ;
KIES, MS ;
LEBEAU, B ;
ONOSHI, T ;
OSTERLIND, K ;
TATTERSALL, MHN ;
WAGNER, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (23) :1618-1624
[8]   Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: A London Lung Cancer Group multicenter randomized clinical trial and meta-analysis [J].
Spiro, Stephen G. ;
James, Lindsay E. ;
Rudd, Robin M. ;
Trask, Colin W. ;
Tobias, Jeffrey S. ;
Snee, Michael ;
Gilligan, David ;
Murray, Philip A. ;
Carmen Ruiz de Elvira, Mary ;
O'Donnell, Katy M. ;
Gower, Nicole H. ;
Harper, Peter G. ;
Hackshaw, Allan K. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) :3823-3830
[9]   Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104 [J].
Takada, M ;
Fukuoka, M ;
Kawahara, M ;
Sugiura, T ;
Yokoyama, A ;
Yokota, S ;
Niskiwaki, Y ;
Watanabe, K ;
Noda, K ;
Tamura, T ;
Fukuda, H ;
Saijo, N .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (14) :3054-3060
[10]   Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide [J].
Turrisi, AT ;
Kim, K ;
Blum, R ;
Sause, WT ;
Livingston, RB ;
Komaki, R ;
Wagner, H ;
Aisner, S ;
Johnson, DH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (04) :265-271
1